Sign In
Buy REGN
$618.95
+16.03 (+2.66%)
At Close: Jun 03, 2026
Is Sanofi on the Verge of Another Blockbuster?
03:00pm, Saturday, 09'th Jul 2022 The Motley Fool
Sanofi and Regeneron's Dupixent could be months away from regulatory approval for another skin condition in the U.S.
This Company Could Ease the Pain in a Bear Market
02:23pm, Saturday, 09'th Jul 2022 The Motley Fool
New product candidates aim to diversify into areas with a large unmet medical need.
7 Moonshot Investments Upending a $10 Trillion Industry
03:53pm, Friday, 08'th Jul 2022
Gene editing is expensive at an estimated $5 billion per drug, but it could change the world in the very near future. The post 7 Moonshot Investments Upending a $10 Trillion Industry appeared first on
Regeneron (REGN) Stock Sinks As Market Gains: What You Should Know
10:15pm, Wednesday, 06'th Jul 2022 Zacks Investment Research
Regeneron (REGN) closed at $594.90 in the latest trading session, marking a -0.28% move from the prior day.
What Stocks To Buy Today? 5 Health Care Stocks To Know
04:30pm, Tuesday, 05'th Jul 2022
Could health care stocks be the best stocks to jump on in the second half of 2022?
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?
01:19pm, Tuesday, 05'th Jul 2022 Zacks Investment Research
Smart Beta ETF report for FXH
3rd-Quarter Clinical Trial Data Could Shake Up Pharma Stocks
11:43am, Tuesday, 05'th Jul 2022
Health care investors would be wise to keep tabs on the results of numerous drug trials scheduled to be revealed in the third quarter. Trial data can impact the stock price of a pharmaceutical company
Should You Invest in the iShares Biotechnology ETF (IBB)?
10:20am, Monday, 04'th Jul 2022 Zacks Investment Research
Sector ETF report for IBB
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates
09:26am, Friday, 01'st Jul 2022 Benzinga
The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled during the month, thanks to a reversal in broader market sentiment.
Only one n
Regeneron (REGN) Dips More Than Broader Markets: What You Should Know
10:15pm, Thursday, 30'th Jun 2022 Zacks Investment Research
Regeneron (REGN) closed at $591.13 in the latest trading session, marking a -1.09% move from the prior day.
5 Top Biotech Stocks To Watch In July 2022
02:30pm, Thursday, 30'th Jun 2022
Amid choppy markets, could there be potential in these top biotech stocks?
Regeneron (REGN) Eylea sBLA for Extended Regimen Accepted
12:56pm, Thursday, 30'th Jun 2022 Zacks Investment Research
FDA accepts Regeneron's (REGN) application seeking label expansion for Eylea for an extended period in patients with diabetic retinopathy.
Regeneron (REGN) Eylea sBLA for Extended Regimen Accepted
10:58am, Thursday, 30'th Jun 2022
FDA accepts Regeneron's (REGN) application seeking label expansion for Eylea for an extended period in patients with diabetic retinopathy.
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?
10:20am, Wednesday, 29'th Jun 2022 Zacks Investment Research
Sector ETF report for FXH
Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA
02:23pm, Saturday, 25'th Jun 2022 The Motley Fool
Mega-blockbuster Dupixent was just given the FDA's green light to treat patients with a chronic, progressive inflammatory disease.
